C07K 14/69
Beta-melanotropin
C07K14/69 (Beta-melanotropin) appears on 9 US grants and 9 published applications in this corpus.
Search patents in C07K- Granted patents
- 9
- Published applications
- 9
- Assignees
- 7
- Inventors
- 24
- Latest grant
- 20 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 0 | 0 |
| 2021 | 2 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages20 May 2025US 12,303,555 B2Nanyang Technological University
- Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages21 Dec 2021US 11,202,820 B2Nanyang Technological University
- Modulators of melanocortin receptors21 Sep 2021US 11,124,542 B2Arizona Board of Regents on Behalf of the University of Arizona
- Enhanced melanoma cancer prevention by novel melanotropins29 Jan 2019US 10,188,704 B2Arizona Board of Regents on Behalf of the University of Arizona
- Pharmaceutical compositions of melanocortin receptor ligands19 Apr 2016US 9,314,509 B2Ipsen Pharma S.A.S.
- Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages3 Mar 2022US 2022/0062387 A1Nanyang Technological University
- Novel modulators of melanocortin receptors10 Oct 2019US 2019/0309022 A1Arizona Board of Regents on Behalf of the University of Arizona
- Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages31 Jan 2019US 2019/0030134 A1Nanyang Technological University
- Enhanced melanoma cancer prevention by novel melanotropins24 May 2018US 2018/0140677 A1Arizona Board of Regents on Behalf of the University of Arizona
- Novel modulators of melanocortin receptors26 Jan 2017US 2017/0022252 A1Arizona Board of Regents on Behalf of the University of Arizona
Most cited
By later US patents
- Hybrid protein101US 4,675,382 APresident and Fellows of Harvard College · 1987
- Melanocyte-stimulating hormone inhibitor and external preparation containing the same10US 5,126,327 ALion Corporation · 1992
- Ligands of melanocortin receptors10US 8,349,797 B2Ipsen Pharma S.A.S. · 2013
- Synthetic amphiphilic glycoconjugates for neurological use2US 5,225,529 AFarmhispania S.A. · 1993